Treatment of Deep Vein Thrombosis Using Factor Xa Inhibitor Concurrent with Platinum Based Chemotherapy Regimen: A Case Report

Author Info

Wan Mohd Akmal Bin Wan Sabri Gobi Hariyanayagam Gunasekaran Mohd Ezrul Helmi Bin Jamaluddin

Corresponding Author

Gobi Hariyanayagam Gunasekaran
Department of Pharmacy, Hospital Seri Manjung, Seri Manjung, Perak, Malaysia

A B S T R A C T

Deep Vein Thrombosis (DVT) is a common treatment-related complication following surgery and chemotherapy. We are reporting a case of colorectal cancer-associated thrombosis during platinum-based chemotherapy. The patient was treated with Rivaroxaban (Xarelto), a highly selective direct Factor Xa inhibitor. This case report highlights the concurrent use of novel oral anticoagulants, which does not interrupt the chemotherapy schedule among patients receiving cytotoxic agents.

Article Info

Article Type

Case Report

Publication history

Received: Tue 01, Jun 2021
Accepted: Tue 07, Sep 2021
Published: Fri 01, Oct 2021

Copyright

© 2023 Gobi Hariyanayagam Gunasekaran. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.CRSS.2021.02.01